A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
GSK’s road to increasing clinical trial transparency is laid out in a document released by EFPIA today. This “road map” can be found here. Researchers can submit proposals and request … Continue Reading GSK’s road to clinical trial transparency
The videos are now available on YouTube from the recent Evidence Live 2015 meeting in Oxford. Presentations available include: Iona Heath – Eminence or evidence-based medicine: why this question is … Continue Reading Videos now available from Evidence Live 2015
The UK Health Research Authority is facing a legal review over its work to advance clinical trial transparency, the Guardian reported this week. The legal review was launched by Richmond … Continue Reading Contract research organisation using court action to challenge data transparency
An Editorial in this week’s New England Journal of Medicine provides a thoughtful overview of the relationship between physicians and industry, and warns of the dangers of bias against industry-sponsored … Continue Reading Understanding industry bias and potential conflicts of interest
Heeding calls from the Institute of Medicine, WHO, and the Nordic Trial Alliance, The BMJ are extending their policy on requiring the sharing of individual patient data for trials of … Continue Reading The BMJ have extended their policy relating to sharing clinical trial data (@bmj_latest)
The aims of the OPEN project (http://www.open-project.eu) are to assess the current evidence on publication bias and to describe current practices by various key groups involved in funding, conducting and … Continue Reading Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN project
A study from the Association of the British Pharmaceutical Industry (ABPI) published this week in the peer-review journal Current Medical Research and Opinion (CMRO) suggests that transparency amongst industry-sponsored clinical … Continue Reading New study suggests that transparency amongst industry-sponsored clinical trials is improving
Most people involved in the development of medical publications – and particularly those from industry – are familiar with the Good Publication Practice (GPP)-2 guidelines, which were published in 2009. … Continue Reading Revised guidelines relating to the development of medical publications to be published in the near future (GPP-3)
A new report, written by Nordic clinical trial experts, sets a high international standard for clinical trial transparency and sets out how to make it a reality. The report from … Continue Reading Nordic researchers want to lead the world in clinical trial transparency
An educational afternoon meeting will be held at Alderley Park in Cheshire on the 3rd of June, entitled: “An update: Publications in Practice”. The programme for this meeting is now … Continue Reading Free educational meeting on medical publications in Cheshire, UK on 3rd June
In a blog today, Iain Hrynaszkiewicz – the Head of Data and HSS Publishing at Nature Publishing Group and Palgrave Macmillan – provides a publisher’s views on improving the reproducibility … Continue Reading The role of openness and publishers in reproducible research
In an article in Trials this week, investigators from the Medical Research Council (MRC) Clinical Trials Unit at the University College London (UCL) provide an overview of their experiences of … Continue Reading Considerations relating to sharing data from clinical trials
The World Health Organization (WHO) today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure … Continue Reading WHO announces new statement on public reporting of clinical trial results
The ISMPP annual meeting will be held in Arlington, USA on the 27-29th April. The meeting will provide attendees with the opportunity to choose from 8 parallel sessions and 9 … Continue Reading The 11th Annual Meeting of the International Society of Medical Publication Professionals (ISMPP) is fast approaching
A study in PLoS One earlier this year found that a relatively high proportion of completed US-based clinical trials did not achieve timely transparency either through publication in peer-review journals … Continue Reading A significant proportion of clinical trials are not published in a timely fashion
According to a study published in the BMJ in March: “Much of the information collected in unsuccessful drug trials is inaccessible to the broader research and practice communities”. The BMJ … Continue Reading Unsuccessful drug trials are less likely to be published in peer reviewed journals